HIV gets the zinc finger
…and survived better than the unaltered lymphocytes, probably because they were at least partially resistant to HIV infection. This important clinical trial is only the beginning of a new approach…
…and survived better than the unaltered lymphocytes, probably because they were at least partially resistant to HIV infection. This important clinical trial is only the beginning of a new approach…
…primates with Ebola virus, it is not known if it would work in humans. Answering that question requires a clinical trial, and the article explores why this phase was not…
…severe fatigue, post-exertional malaise, pain, cognitive and sleep problems that affects 0.1-0.2% of the population. A previous randomized, phase II trial of rituximab treatment showed clinical benefit in 20 of…
…the virus. The results of a phase 3 clinical trial indicated that immunization protected not only against primary infection, but also against severe disease. Dengvaxia was licensed based on data…
…are open label trials relying on subjective outcomes. Trials with this design are fraught with bias, which is why they are no longer considered as reliable evidence for making decisions…
…escalated development and sent vaccine to NIAID to begin the process of initiating a phase I trial to test the safety and immunogenicity of the vaccine. The trial is projected…